The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 24, Issue 2, Pages 454-462
Publisher
Oxford University Press (OUP)
Online
2012-08-23
DOI
10.1093/annonc/mds329
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer
- (2012) Jill M. Binkley et al. CANCER
- The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA
- (2012) Sherry L. Wolf et al. SUPPORTIVE CARE IN CANCER
- Responsiveness and minimal important score differences in quality-of-life questionnaires: a comparison of the EORTC QLQ-C30 cancer-specific questionnaire to the generic utility questionnaires EQ-5D and 15D in patients with multiple myeloma
- (2011) Ann Kristin Kvam et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics
- (2011) Guido Cavaletti et al. LANCET ONCOLOGY
- Rasch-built Overall Disability Scale (R-ODS) for immune-mediated peripheral neuropathies
- (2011) S. I. van Nes et al. NEUROLOGY
- Chemotherapy-Induced Peripheral Neurotoxicity assessment: A critical revision of the currently available tools
- (2010) Guido Cavaletti et al. EUROPEAN JOURNAL OF CANCER
- The measurement of disease
- (2010) I. S. J. Merkies et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials
- (2010) John T. Maringwa et al. SUPPORTIVE CARE IN CANCER
- A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA
- (2010) Debra L. Barton et al. SUPPORTIVE CARE IN CANCER
- Assessment of Quality of Life After Gastrectomy Using EORTC QLQ-C30 and STO22
- (2010) Daisuke Kobayashi et al. WORLD JOURNAL OF SURGERY
- CI-PERINOMS: chemotherapy-induced peripheral neuropathy outcome measures study
- (2009) JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Patient-reported outcomes: Assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency
- (2008) Andrew Bottomley et al. EUROPEAN JOURNAL OF CANCER
- Revising two-point discrimination assessment in normal aging and in patients with polyneuropathies
- (2008) S I van Nes et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Outcome measures in immune-mediated neuropathies: the need to standardize their use and to understand the clinimetric essentials
- (2008) Sonja I. van Nes et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More